Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct:289:121612.
doi: 10.1016/j.biortech.2019.121612. Epub 2019 Jun 6.

Efficient bioconversion of epimedin C to icariin by a glycosidase from Aspergillus nidulans

Affiliations

Efficient bioconversion of epimedin C to icariin by a glycosidase from Aspergillus nidulans

Yunbin Lyu et al. Bioresour Technol. 2019 Oct.

Abstract

Herba Epimedii is a traditional Chinese herbal medicine that contains a mixture of bioactive flavonoid glycosides. Among them, icariin has the most outstanding bioactive functions, while epimedin C exhibits substantial toxicity. A recombinant α-L-rhamnosidase (synAnRhaE) from Aspergillus nidulans was expressed in Escherichia coli to promote the efficient bioconversion of epimedin C to icariin. A hydrolase activity of 574.5 U L-1 was acquired via optimized fed-batch fermentation in a 5-L bioreactor. The enzyme proved to be stable in an acidulous pH range below 55 °C with an optimal pH of 4.5 and optimal temperature of 55 °C. Epimedin C (1 g L-1) was 100% converted to icariin within 90 min using recombinant cells. The resting cells proved to be selective for epimedin C and 2″-O-rhamnosylicariside II in crude extracts of the epimedium plant. This work provides an original and efficient biocatalyst system that can be applied in industrialized production of icariin.

Keywords: Aspergillus nidulans; Bioconversion; Epimedin C; Icariin; α-L-Rhamnosidase.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources